Home » Topics » BioWorld Science

BioWorld Science
RSS

Ciba-Geigy describes trypsin/thrombin inhibitors

Nov. 15, 1996

Hyal and The Hospital for Sick Children vascular disease collaboration

Nov. 15, 1996

Cypros acquires well-established Rx for esophageal varices

Nov. 15, 1996

Human pharmacokinetic/pharmacodynamic studies on bosentan

Nov. 15, 1996

NEP and ECE inhibitors reported by Kali-Chemie

Nov. 15, 1996

Clinical trials update on nibentan, Russian antiarrhythmic drug

Nov. 15, 1996

Chugai discloses antiischemic agents

Nov. 15, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

Biovail licenses once-daily diltiazem

Nov. 15, 1996

Endothelin antagonists claimed by E. Merck

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...